Brain scan breakthrough: same accuracy with 84% less dye?
NCT ID NCT04113395
Summary
This study tested whether a special type of MRI scan could detect a common brain tumor called a meningioma using a much smaller dose of contrast dye. Researchers compared new scanning techniques using only one-sixth of the standard dye dose against the current best method in 514 patients. The goal was to find a safer way to screen for these tumors, especially for people who need repeated scans over their lifetime.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux
Bordeaux, 33076, France
-
CHU de Grenoble
Grenoble, Grenoble, 38100, France
-
CHU de Limoges
Limoges, Limoges, 87042, France
-
CHU de Lyon
Lyon, Lyon, 69495, France
-
CHU de Nantes
Nantes, Nantes, 44800, France
-
CHU de Rennes
Rennes, Rennes, 35033, France
-
CHU de Rouen
Rouen, Rouen, 76000, France
-
CHU de Strasbourg
Strasbourg, Strasbourg, 67000, France
-
CHU de Tours
Tours, Tours, France
-
Fondation ophtalmique Adolphe de Rothschild
Paris, Paris, 75019, France
Conditions
Explore the condition pages connected to this study.